COVID 19 DRUG
US: Former Pfizer Employee, Accomplice From India Charged With Insider Trading on COVID-19 Drug Trial
Molnupiravir, COVID-19 Antiviral Drug, Launched in India at Rs 1,399 For Mild to Moderate Infection
COVID-19 Drug Molnupiravir May Reduce Risk of Hospitalisation and Death in Newly-Diagnosed Patients, Says Health Expert Dr Krishna Reddy Nallamalla
DRDO to Get 2% Royalty from Dr Reddy's On Sale of Anti-COVID-19 Drug 2-DG in India, Says MoS Defence Ajay Bhatt
COVID-19 Drug In India Soon, Five Drugmakers To Jointly Start Trial Of Merck & Co's Coronavirus Medicine
Reliance Industries Limited Submits Proposal for ‘Niclosamide’ As Potential Drug Against COVID-19
2-DG, DRDO's Anti COVID-19 Drug, Will Reduce Recovery Time, Oxygen Dependency, Says Dr Harsh Vardhan
Tamil Nadu: Amid Rising COVID-19 Cases, Huge Crowd Seen Outside Jawaharlal Nehru Stadium in Chennai To Get Remdesivir (See Pics)
Remdesivir Black-Marketing Racket Busted by Chhattisgarh Police; 4 Arrested With Anti-Viral COVID-19 Drug in Raipur
Google Trends